Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides.
about
EndothelinEndothelin-converting enzymes and related metalloproteases in Alzheimer's diseaseAnimals lacking endothelin-converting enzyme-2 are deficient in learning and memory.Homology modeling and site-directed mutagenesis to identify selective inhibitors of endothelin-converting enzyme-2Identification of an endothelin-converting enzyme-2-specific fluorigenic substrate and development of an in vitro and ex vivo enzymatic assayOpioid receptor function is regulated by post-endocytic peptide processing.Quantitative peptidomics of Purkinje cell degeneration miceAmyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin.Mice deficient in endothelin-converting enzyme-2 exhibit abnormal responses to morphine and altered peptide levels in the spinal cordNeuropeptide-processing enzymes: applications for drug discovery.Identification of endothelin-converting enzyme-2 as an autoantigen in autoimmune polyendocrine syndrome type 1.Peptidomics of Cpe(fat/fat) mouse brain regions: implications for neuropeptide processingEndothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Abeta.Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease.Endothelin-converting enzyme 2 differentially regulates opioid receptor activity.Histochemical distribution of endothelin-converting enzyme subtypes in Podarcis sicula (Squamata, Lacertidae) tissues.Neprilysin Inhibitors and Bradykinin
P2860
Q26767156-CE1CFD91-0754-4797-B429-81C7C58CF358Q26862901-3C507E06-7A68-448A-B6CD-648600DF4EDBQ30495123-7740CB4E-8451-4156-A228-A95C47167D77Q33338181-2A0AF316-509D-4181-834D-26645EF08EADQ33679572-E6048050-721D-438F-B382-0D0738384CFCQ33888590-0052AEB6-60C5-40F9-B681-7699B4A330ECQ34674422-AB1DB677-ED7D-4B68-BF04-87E7BC728DCAQ34777829-F5CFDE1B-3DBC-41AE-9CED-D95DF11BA4AFQ35552722-5E1B5CEB-B954-4A04-A8C9-5B82296F6EF7Q36341621-DB118A28-EF7B-497A-B521-7DD2CDB5D50CQ36384776-5D4CC2B1-B3E2-4E8C-8FD6-51A5CCF61D32Q37146747-E7909992-C075-4D63-A5DE-1868AE3CCCEEQ37257169-12F42CE0-E611-43E5-8DAC-C0E8848DF171Q37961852-4CE85EB2-2B8D-4682-9049-3119D98F77B9Q38256360-5E898B5A-9365-48A8-8E82-FB83BF19DA22Q41891837-06AF9A90-0C19-4FF8-9503-DB6241A5441FQ46726041-39C3F2CD-A3AE-4402-A38F-D7B528B637B1Q57072764-98D25F4B-8967-4C1F-B1B1-15BB64767EEE
P2860
Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 January 2003
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization of endothelin ...... essing of regulatory peptides.
@en
Characterization of endothelin ...... essing of regulatory peptides.
@nl
type
label
Characterization of endothelin ...... essing of regulatory peptides.
@en
Characterization of endothelin ...... essing of regulatory peptides.
@nl
prefLabel
Characterization of endothelin ...... essing of regulatory peptides.
@en
Characterization of endothelin ...... essing of regulatory peptides.
@nl
P2093
P2860
P356
P1476
Characterization of endothelin ...... essing of regulatory peptides.
@en
P2093
Fa-Yun Che
Lakshmi A Devi
Lloyd D Fricker
Nino Mzhavia
P2860
P304
14704-14711
P356
10.1074/JBC.M211242200
P407
P577
2003-01-30T00:00:00Z